title: Immunosuppressive treatment for giant cell arteritis: where do we stand?
authors.affiliation: Rheumatology Unit, Department of Internal Medicine, Azienda Ospedaliera ASMN, IRCCS Reggio Emilia, Italy.
authors.forename: N
authors.initials: N
authors.lastname: Pipitone
authors.affiliation: Rheumatology Unit, Department of Internal Medicine, Azienda Ospedaliera ASMN, IRCCS Reggio Emilia, Italy.
authors.forename: C
authors.initials: C
authors.lastname: Salvarani
mesh_terms: D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D013700:Giant Cell Arteritis / Q000188:drug therapy*; D005938:Glucocorticoids / Q000627:therapeutic use*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008727:Methotrexate / Q000627:therapeutic use*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D005938:Glucocorticoids; D007166:Immunosuppressive Agents; D014409:Tumor Necrosis Factor-alpha; C502936:tocilizumab; D008727:Methotrexate